From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase
about
Eating disorders in schizophrenia: implications for research and managementAlterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gainManagement of antipsychotic-related weight gainEndocrine disrupters as obesogensInternational Union of Basic and Clinical Pharmacology. XCVIII. Histamine ReceptorsAssociation between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylationSynthesis and evaluation of a series of 2-substituted-5-thiopropylpiperazine (piperidine)-1,3,4-oxadiazoles derivatives as atypical antipsychoticsPreventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatmentKetamine-induced brain activation in awake female nonhuman primates: a translational functional imaging model.Long-term risperidone treatment induces visceral adiposity associated with hepatic steatosis in mice: a magnetic resonance approachReal-world Data on Atypical Antipsychotic Medication Side EffectsHigh fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice.Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intakeLeptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents.Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions.Acute effects of betahistine hydrochloride on food intake and appetite in obese women: a randomized, placebo-controlled trialNovel olanzapine analogues presenting a reduced H1 receptor affinity and retained 5HT2A/D2 binding affinity ratio.Serotonin (5-HT) affects expression of liver metabolic enzymes and mammary gland glucose transporters during the transition from pregnancy to lactationBody weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.Antipsychotic drugs and obesity.Discovery, optimization, and characterization of novel D2 dopamine receptor selective antagonists.In vivo pharmacological evaluations of novel olanzapine analogues in rats: a potential new avenue for the treatment of schizophreniaMetabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophreniaAtypical antipsychotics and the neural regulation of food intake and peripheral metabolism.Illuminating the molecular basis for some antipsychotic drug-induced metabolic burden.Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat.Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents.Olanzapine causes a leptin-dependent increase in acetylcholine release in mouse prefrontal cortex.Double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder.Central nervous system delivery of the antipsychotic olanzapine induces hepatic insulin resistanceDesipramine inhibits histamine H1 receptor-induced Ca2+ signaling in rat hypothalamic cells.Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.Safety and tolerability of antipsychotic polypharmacy.Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs.Clozapine modifies the differentiation program of human adipocytes inducing browning.Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats.Histamine receptor signaling in energy homeostasis.Role of 5-HT(2C) receptor gene variants in antipsychotic-induced weight gain.
P2860
Q21284525-FADC5F8E-CF1C-4602-93F4-D2E69A040A73Q21561008-259E11A6-1401-41EB-992F-12D78896AB40Q24610124-8A07A245-9E54-4037-B4AA-C06B8AEEF682Q24647272-E8FA4B71-FE50-49DB-80BC-8E84F1C56289Q26827568-0BE2C988-07B0-429D-8613-DA6271234023Q28264722-2943BC67-5462-434E-A04B-FA94B9A72936Q28478539-E5FF8C2D-59A3-4742-997F-DA4EC7248588Q28483019-1899B973-5BD8-4BAD-A541-9A06C7FEC050Q28541531-9FA3D01F-D9AC-4C8C-9511-7B42F573EE89Q30714646-87DA2344-0FCE-447D-A79E-C94D1AFDB68BQ33607534-12A4C4E0-0074-40D1-82A7-E8E456332CBAQ33678816-A03AF703-1373-46A9-8D7A-9C66D9A5880BQ33850466-E22886AA-868E-4EFA-B765-5CA6B2A57B9CQ34006864-023FA1D1-A412-41A1-A8A0-4CB7A6261164Q34025489-3FC27A95-F10F-4B8F-8DD1-62805CB1C4C0Q34056408-BF8096A9-2906-4DF2-8170-6BFB0CF51EBAQ34248044-5FB58A7C-FA4B-42D8-9B2B-F90A88B676BFQ34308035-5641B00E-1B10-4179-865E-6AEE6E34670FQ34314781-5DA2829F-1B67-44EB-BEA3-B599BFF57D73Q34612523-6F2F4947-5406-42AD-85A8-ECD7A3BDCA85Q34641561-966948A1-289D-4185-BE91-D6CC4C189E63Q34648940-F8561F7C-3544-4924-AD97-908E93F8C058Q35043389-6B5F3C81-D524-4FF6-9CDE-9D7A735B7C86Q35069463-5FDAD515-3296-4E2C-B67C-DDFD1A39D1BCQ35082389-18412567-AD06-48EF-87B6-2EF0447EB996Q35115972-9BEE5A47-E47A-4BAB-9950-0441D3837604Q35652340-7D855182-FE64-4364-B042-081D1E8772A9Q35675775-E1FD916E-C089-4123-80D9-DFD5FD6B6957Q35700356-9DCFE237-FBD6-40CB-A33A-3C47496E3EFFQ35741827-63075C8F-D8A9-4C3E-A66E-D22AD77DD97DQ35745299-E56EFC20-0D8D-4300-89DC-198FFE65C1B7Q35757166-7BA23ED7-2EDB-4855-81F9-701EEFDA7194Q35918173-3235B15A-0F9C-43DC-A337-06A7670ECD83Q35973931-82DA003B-FEC5-4585-88E9-5D564A0A3D37Q36062421-F6F034BE-0098-4189-8166-2BD41155D049Q36063735-411C9D3B-1B77-4333-B99B-26B06734724FQ36206591-636ECA59-30ED-4DC3-A5F2-F4097D20A71BQ36383322-32F71D1F-F179-4935-9158-A19B3FF23562Q36391171-42BFC90D-A018-41A3-A446-D7C945737BA7Q36441507-1E753172-8B99-4C32-AE1B-56C3A3108356
P2860
From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
From the Cover: Antipsychotic ...... ion of hypothalamic AMP-kinase
@ast
From the Cover: Antipsychotic ...... ion of hypothalamic AMP-kinase
@en
From the Cover: Antipsychotic ...... ion of hypothalamic AMP-kinase
@nl
type
label
From the Cover: Antipsychotic ...... ion of hypothalamic AMP-kinase
@ast
From the Cover: Antipsychotic ...... ion of hypothalamic AMP-kinase
@en
From the Cover: Antipsychotic ...... ion of hypothalamic AMP-kinase
@nl
prefLabel
From the Cover: Antipsychotic ...... ion of hypothalamic AMP-kinase
@ast
From the Cover: Antipsychotic ...... ion of hypothalamic AMP-kinase
@en
From the Cover: Antipsychotic ...... ion of hypothalamic AMP-kinase
@nl
P2093
P2860
P3181
P356
P1476
From the Cover: Antipsychotic ...... ion of hypothalamic AMP-kinase
@en
P2093
Adele M Snowman
Alex S Huang
Cory Teuscher
Sangwon F Kim
P2860
P304
P3181
P356
10.1073/PNAS.0611417104
P407
P577
2007-02-27T00:00:00Z